Literature DB >> 16492573

Reflections on smoking relapse research.

Saul Shiffman1.   

Abstract

This paper presents personal reflections on the history, current status and the future of research on smoking relapse. Relapse was traditionally viewed primarily as an outcome, to be reduced with increased treatment. In the 1980s, relapse research was invigorated by a focus on the process of relapse, focusing on the specific situations in which lapses to smoking occurred, and on the processes that mediated progression from a lapse to a relapse. This line of research had substantial influence on treatment, but has currently been displaced by a return to a pure outcomes-focus, driven in part by the practical need to find treatments that work and to package them for dissemination. At the same time, technological and methodological developments have enabled detailed monitoring of experience and behaviour throughout the relapse process, and progression of these developments will make monitoring of relapse process compelling in the future. The need to understand how interventions work will also drive a resurgence of research on the relapse process. Finally, the same technological and conceptual developments that enable detailed monitoring of behaviour will spawn the development of just-in-time interventions that are offered and implemented as needed, rather than being addressed in the abstract in advance of the need.

Mesh:

Year:  2006        PMID: 16492573     DOI: 10.1080/09595230500459479

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  29 in total

1.  Boosting population quits through evidence-based cessation treatment and policy.

Authors:  David B Abrams; Amanda L Graham; David T Levy; Patricia L Mabry; C Tracy Orleans
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

2.  Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Authors:  John A Dani; Mariella De Biasi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

3.  A dynamical systems approach to understanding self-regulation in smoking cessation behavior change.

Authors:  Kevin P Timms; Daniel E Rivera; Linda M Collins; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2013-09-24       Impact factor: 4.244

4.  Momentary precipitants connecting stress and smoking lapse during a quit attempt.

Authors:  Christopher Cambron; Aaron K Haslam; Brian R W Baucom; Cho Lam; Christine Vinci; Paul Cinciripini; Liang Li; David W Wetter
Journal:  Health Psychol       Date:  2019-09-26       Impact factor: 4.267

5.  Distress tolerance treatment for early-lapse smokers: rationale, program description, and preliminary findings.

Authors:  Richard A Brown; Kathleen M Palm; David R Strong; Carl W Lejuez; Christopher W Kahler; Michael J Zvolensky; Steven C Hayes; Kelly G Wilson; Elizabeth V Gifford
Journal:  Behav Modif       Date:  2008-05

6.  The day-to-day process of stopping or reducing smoking: a prospective study of self-changers.

Authors:  Erica N Peters; John R Hughes
Journal:  Nicotine Tob Res       Date:  2009-06-26       Impact factor: 4.244

7.  Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  J Pharmacol Exp Ther       Date:  2010-04-30       Impact factor: 4.030

8.  Smoking prevalence and factors associated with smoking status among Vietnamese in California.

Authors:  E K Tong; G Gildengorin; T Nguyen; J Tsoh; M Modayil; C Wong; S J McPhee
Journal:  Nicotine Tob Res       Date:  2010-05-20       Impact factor: 4.244

9.  Lapse-induced surges in craving influence relapse in adult smokers: an experimental investigation.

Authors:  William G Shadel; Steven C Martino; Claude Setodji; Daniel Cervone; Katie Witkiewitz; Ellen Burke Beckjord; Deborah Scharf; Regina Shih
Journal:  Health Psychol       Date:  2011-09       Impact factor: 4.267

10.  A digital smoking cessation program delivered through internet and cell phone without nicotine replacement (happy ending): randomized controlled trial.

Authors:  Håvar Brendryen; Filip Drozd; Pål Kraft
Journal:  J Med Internet Res       Date:  2008-11-28       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.